Radiation Recall Dermatitis with Azithromycin
نویسندگان
چکیده
منابع مشابه
Radiation recall dermatitis with azithromycin.
Radiation recall is a well-known phenomenon that involves the "recall" of an acute inflammatory reaction in a previously irradiated region after administration of certain drugs. The most common type of radiation recall is radiation recall dermatitis, which involves the reoccurrence of an acute inflammatory skin reaction in previously irradiated skin. Most radiation recall reactions are attribut...
متن کاملTamoxifen-induced radiation recall dermatitis.
To the Editor: Radiation recall dermatitis is a phenomenon seen in patients who have received radiation therapy followed by chemotherapy. Tamoxifen, a selective estrogen receptor (ER) modulator, has been implicated in three cases of radiation recall dermatitis (1–3). We report a fourth case, which we believe to be the first reaction documented in the United States. An 88-year-old woman was diag...
متن کاملRadiation recall dermatitis with cefotetan: a case study.
Radiation recall dermatitis (RRD) is an inflammatory skin reaction that occurs in a previously irradiated body part following drug administration. This phenomenon may occur from days to years following exposure to ionizing radiation. The case of a 54-year-old Caucasian woman who was initially treated with external-beam radiation to the right thoracic region following the diagnosis of a poorly d...
متن کاملRadiation Recall Dermatitis after Treatment with Paclitaxel and Cisplatin
Received March 28, 2011, Revised June 29, 2011, Accepted for publication July 5, 2011 Corresponding author: Hyo Jin Lee, M.D., Department of Internal Medicine, Chungnam National University Hospital, 640 Daesa-dong, Jung-gu, Daejeon 301-721, Korea. Tel: 82-42-280-8369, Fax: 82-42-257-5753, E-mail: [email protected] This is an Open Access article distributed under the terms of the Creative Commons ...
متن کاملSorafenib-triggered radiation recall dermatitis with a disseminated exanthematous reaction
Sorafenib is a multi-targeted kinase inhibitor, which is the current standard treatment for advanced hepatocellular carcinoma (HCC). Only one case of radiation recall dermatitis (RRD) associated with sorafenib has been reported so far. Our patient with recurrent HCC was treated with palliative radiotherapy (RT) for the chest wall mass. Sorafenib at 400 mg twice daily was begun on the day follow...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Oncology
سال: 2010
ISSN: 1718-7729
DOI: 10.3747/co.v17i4.488